• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>The Australian and New Zealand journal of psychiatry >Cost of high prevalence mental disorders: Findings from the 2007 Australian National Survey of Mental Health and Wellbeing
【24h】

Cost of high prevalence mental disorders: Findings from the 2007 Australian National Survey of Mental Health and Wellbeing

机译：患有高患病率的成本精神障碍：2007年澳大利亚国家心理健康和福祉调查的调查结果

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Objective: The aim of this project was to detail the costs associated with the high prevalence mental disorders (depression, anxiety-related and substance use) in Australia, using community-based, nationally representative survey data. Methods: Respondents diagnosed, within the preceding 12?months, with high prevalence mental disorders using the Confidentialised Unit Record Files of the 2007 National Survey of Mental Health and Wellbeing were analysed. The use of healthcare resources (hospitalisations, consultations and medications), productivity loss, income tax loss and welfare benefits were estimated. Unit costs of healthcare services were obtained from the Independent Hospital Pricing Authority, Medicare and Pharmaceutical Benefits Scheme. Labour participation rates and unemployment rates were determined from the National Survey of Mental Health and Wellbeing. Daily wage rates adjusted by age and sex were obtained from Australian Bureau of Statistics and used to estimate productivity losses. Income tax loss was estimated based on the Australian Taxation Office rates. The average cost of commonly received Government welfare benefits adjusted by age was used to estimate welfare payments. All estimates were expressed in 2013–2014 AUD and presented from multiple perspectives including public sector, individuals, private insurers, health sector and societal. Results: The average annual treatment cost for people seeking treatment was AUD660 (public), AUD195 (individual), AUD1058 (private) and AUD845 from the health sector’s perspective. The total annual healthcare cost was estimated at AUD974m, consisting of AUD700m to the public sector, AUD168m to individuals, and AUD107m to the private sector. The total annual productivity loss attributed to the population with high prevalence mental disorders was estimated at AUD11.8b, coupled with the yearly income tax loss at AUD1.23b and welfare payments at AUD12.9b. Conclusion: The population with high prevalence mental disorders not only incurs substantial cost to the Australian healthcare system but also large economic losses to society.
机译：目的：本项目的目的是利用基于社区、具有全国代表性的调查数据，详细说明澳大利亚高患病率精神障碍（抑郁、焦虑相关和药物使用）的相关成本。方法：在前12年内确诊的受访者？使用2007年全国心理健康和福祉调查的保密单位记录文件，对高患病率的精神障碍患者进行了分析。对医疗资源的使用（住院、咨询和药物）、生产力损失、所得税损失和福利进行了估计。医疗服务的单位成本来自独立医院定价管理局、医疗保险和药品福利计划。劳动参与率和失业率由全国心理健康和福利调查确定。按年龄和性别调整的日工资率来自澳大利亚统计局，用于估算生产率损失。所得税损失是根据澳大利亚税务局的税率估算的。按年龄调整后的政府福利金平均成本用于估计福利支出。所有估算均以2013年至2014年的澳元表示，并从公共部门、个人、私营保险公司、卫生部门和社会等多个角度呈现。结果：从卫生部门的角度来看，寻求治疗的人的平均年治疗费用为660澳元（公共）、195澳元（个人）、1058澳元（私人）和845澳元。年度医疗保健总成本估计为9.74亿澳元，其中公共部门为7亿澳元，个人为1.68亿澳元，私营部门为1.07亿澳元。据估计，高患病率精神障碍人群每年的总生产力损失为11澳元。80亿澳元，加上每年1澳元的所得税损失。23b和12澳元的福利金。9b。结论：精神障碍高发人群不仅给澳大利亚医疗系统带来了巨大的成本，也给社会带来了巨大的经济损失。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号